Noven Pharma (BRISDELLE and PEXEVA) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Noven Pharma (BRISDELLE and PEXEVA) General Information

Description

Manufacturer of pharmaceutical products. The company manufactures, supplies and distributes two drugs namely Brisdelle (Paroxetine) Capsules, 7.5 mg and Pexeva (Paroxetine Mesylate) tablets used to treat moderate to severe vasomotor menopausal symptoms and depression, panic attacks, obsessive-compulsive disorder (OCD) respectively.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 11960 South West
  • 144th Street
  • Miami, FL 33186
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Medical Supplies
Vertical(s)
Corporate Office
  • 11960 South West
  • 144th Street
  • Miami, FL 33186
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noven Pharma (BRISDELLE and PEXEVA) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Noven Pharma (BRISDELLE and PEXEVA)‘s full profile, request access.

Request a free trial

Noven Pharma (BRISDELLE and PEXEVA) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Noven Pharma (BRISDELLE and PEXEVA)‘s full profile, request access.

Request a free trial

Noven Pharma (BRISDELLE and PEXEVA) FAQs

  • Where is Noven Pharma (BRISDELLE and PEXEVA) headquartered?

    Noven Pharma (BRISDELLE and PEXEVA) is headquartered in Miami, FL.

  • What industry is Noven Pharma (BRISDELLE and PEXEVA) in?

    Noven Pharma (BRISDELLE and PEXEVA)’s primary industry is Pharmaceuticals.

  • Is Noven Pharma (BRISDELLE and PEXEVA) a private or public company?

    Noven Pharma (BRISDELLE and PEXEVA) is a Private company.

  • What is Noven Pharma (BRISDELLE and PEXEVA)’s current revenue?

    The current revenue for Noven Pharma (BRISDELLE and PEXEVA) is .

  • Who are Noven Pharma (BRISDELLE and PEXEVA)’s investors?

    Noven Pharmaceuticals has invested in Noven Pharma (BRISDELLE and PEXEVA).

  • When was Noven Pharma (BRISDELLE and PEXEVA) acquired?

    Noven Pharma (BRISDELLE and PEXEVA) was acquired on 26-Jul-2016.

  • Who acquired Noven Pharma (BRISDELLE and PEXEVA)?

    Noven Pharma (BRISDELLE and PEXEVA) was acquired by Sebela Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »